Back to search

France· FR:60774228

RILMENIDINE EG 1 mg, comprimé

A medicinal product containing dihydrogénophosphate de rilménidine, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedRILMENIDINE EG 1 mg, compriméATC—REGISTER NO.FR:60774228PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DIHYDROGÉNOPHOSPHATE DE RILMÉNIDINE
Manufacturer
EG LABO - LABORATOIRES EUROGENERICS
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400937500326
    plaquette(s) aluminium de 30 comprimé(s)
    EUR 4.65
  • cip13
    3400937500555
    plaquette(s) aluminium de 90 comprimé(s)
    EUR 13.08

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dihydrogénophosphate de rilménidine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dihydrogénophosphate de rilménidine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Iterium, Rilmenidin Grindeks
  • Bulgaria · Рилменидин Гриндекс, Рилменикс
  • Czechia · Rilmenidin Teva, Rilmenidine Grindeks
  • Estonia · Rilmenidine Grindeks
  • Hungary · Hyperlex, Rilmenidin Teva
  • Lithuania · Rilmenidine Grindeks, Rilmenidine Teva
  • Luxembourg · Hyperium
  • Latvia · Rilmenidine Grindeks, Rilmenidine Teva
  • Poland · Rilmenidine Grindeks, Tenaxum
  • Portugal · Hyperium, Rilmenidina Grindeks
  • Romania · Rilmenidină Grindeks, Taruza
  • Slovakia · Rilmenidin Teva, Rilmenidine Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df5b7cf7-e7da-4d72-b8c5-9c22f1bbf8c9
GET /v1/drugs/df5b7cf7-e7da-4d72-b8c5-9c22f1bbf8c9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60774228",
  "date_amm": "2006-04-14",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "DIHYDROGÉNOPHOSPHATE DE RILMÉNIDINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about dihydrogénophosphate de rilménidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.